🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Determine the doses and schedule appropriate for phase 2 study of sorafenib...
Status
Completed
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2015-01-29
Trial ID
NCT02349867
This phase I trial is studying the side effects and best dose of temsirolim...
Status
Completed
Location
Mayo Clinic in Florida
Start Date
2006-05
Trial ID
NCT00316849
This randomized phase II-R/III trial studies gemcitabine hydrochloride with...
Status
Completed
Location
Providence Hospital
Start Date
2010-04-05
Trial ID
NCT01013649
This randomized phase II/III trial studies how well giving maintenance chem...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2017-04-07
Trial ID
NCT03137771
The study aims to compare the incidence of acute grade 2 GI toxicity in the...
Status
Terminated
Location
St Luke's Radiation Oncology Network at Beaumont Hospital
Start Date
2014-10-17
Trial ID
NCT02151019
Treatments Being Tested
Nab-paclitaxel and carboplatin showed better treatment response compared wi...
Status
Unknown
Location
Hangzhou Cancer Hospital
Start Date
2012-07
Trial ID
NCT01494415
Treatments Being Tested
RATIONALE: Specialized radiation therapy that delivers a high dose of radia...
Status
Unknown
Location
Kantonsspital Aarau
Start Date
2006-08
Trial ID
NCT00392470
RATIONALE: Imaging procedures, such as PET scans, may determine the extent ...
Status
Completed
Location
Centre Oscar Lambret
Start Date
2007-05
Trial ID
NCT00809016
Head \& Neck squamous cell carcinomas are the commonest cancers afflicting ...
Status
Unknown
Location
Tata Memorial Hospital
Start Date
2005-08
Trial ID
NCT00652613
Treatments Being Tested
This randomized phase III trial studies pelvic radiation therapy to see how...
Status
Unknown
Location
University of Alabama at Birmingham Cancer Center
Start Date
2009-03-23
Trial ID
NCT00807768